Related Experiment Video
Updated: Mar 7, 2026
08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
16.3K
[Microbial Biomarkers for Early Cancer Detection]
Deutsche Medizinische Wochenschrift (1946)
|February 25, 2017
Summary
The human microbiome, comprising trillions of microbes, is crucial for health. Alterations in the gut microbiome show potential for early cancer detection and prognosis, particularly for colorectal cancer.
Area of Science:
- Microbiology
- Oncology
- Biomarker Discovery
Background:
- The human microbiome plays a vital role in maintaining health.
- Altered microbiome composition is associated with various diseases, including cancer.
- Understanding these associations is key for developing new diagnostic and prognostic tools.
Purpose of the Study:
- To summarize recent advancements in microbiome-based cancer biomarkers.
- To highlight the potential of gut microbiome alterations for early cancer detection.
- To discuss the limitations and challenges in developing these biomarkers.
Main Methods:
- Review of current research on microbiome alterations in cancer.
- Identification of microbial taxonomic markers in fecal samples.
- Analysis of potential for non-invasive diagnostic and prognostic tests.
Main Results:
- Specific microbial markers, like Fusobacterium nucleatum, are found in feces.
- These markers show promise for non-invasive diagnostics and prognostics in colorectal cancer.
- Microbiome alterations are observable across different disease stages.
Conclusions:
- Gut microbiome research offers promising avenues for cancer early detection.
- Microbial biomarkers, especially for colorectal cancer, are nearing clinical application.
- Further research is needed to overcome limitations and challenges in biomarker development.
